www.GreenStocksOnline.com: GreenCell, Inc. (OTCBB: GCLL) Locks Up Rare Earth Material Suppliers

   GreenCell, Inc. (OTCBB: GCLL) who develops, commercialize and markets ceramic composite materials for home and transportation applications, recently announced that they have developed overseas suppliers of rare earth materials to ensure price and supply options for use in their igniter and automotive products.

Currently China supplies over 90% of the global supply of rare earth metals and elements, with 70% of the world's production coming from a single mine. China has indicated it plans to limit export amounts to retain rare earths for its own industrial use. By GreenCell developing these suppliers they can assure an uninterrupted flow of essential materials to produce UltraTemp products.

Greencell is the exclusive worldwide licensee of the UltraTemp™ ceramic technology under perpetual license from Sencer, Inc. Greencell is in the process of developing, commercializing and marketing UltraTemp™ for multiple applications.

For more information, please visit www.greenstocksonline.com

Other active stocks are DoMark International (OTCBB: DOMK), Liquidmetal Tech (OTCBB: LQMT) and SEFE, Inc (OTCBB: SEFE)

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid OTC Report one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. However, no representation, expressed or implied, is made as to the accuracy, completeness or correctness. In light of the above, we accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

OTC Report Email Contact